Carolinas Wealth Consulting’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-568
| Closed | -$11.8K | – | 60 |
|
|
2025
Q1 | $11.8K | Hold |
568
| – | – | ﹤0.01% | 509 |
|
|
2024
Q4 | $13.4K | Sell |
568
-1,062
| -65% | -$25K | ﹤0.01% | 517 |
|
|
2024
Q3 | $41.7K | Sell |
1,630
-529
| -25% | -$13.5K | 0.01% | 389 |
|
|
2024
Q2 | $50.7K | Sell |
2,159
-378
| -15% | -$8.87K | 0.01% | 361 |
|
|
2024
Q1 | $73K | Sell |
2,537
-759
| -23% | -$21.8K | 0.01% | 320 |
|
|
2023
Q4 | $108K | Sell |
3,296
-1,241
| -27% | -$40.7K | 0.02% | 222 |
|
|
2023
Q3 | $104K | Sell |
4,537
-1,040
| -19% | -$23.9K | 0.03% | 212 |
|
|
2023
Q2 | $190K | Hold |
5,577
| – | – | 0.04% | 176 |
|
|
2023
Q1 | $168K | Sell |
5,577
-298
| -5% | -$8.96K | 0.04% | 189 |
|
|
2022
Q4 | $166K | Sell |
5,875
-1,620
| -22% | -$45.7K | 0.04% | 185 |
|
|
2022
Q3 | $246K | Sell |
7,495
-535
| -7% | -$17.6K | 0.06% | 133 |
|
|
2022
Q2 | $253K | Sell |
8,030
-926
| -10% | -$29.2K | 0.06% | 133 |
|
|
2022
Q1 | $411K | Sell |
8,956
-2,252
| -20% | -$103K | 0.09% | 101 |
|
|
2021
Q4 | $689K | Sell |
11,208
-390
| -3% | -$24K | 0.15% | 76 |
|
|
2021
Q3 | $867K | Sell |
11,598
-407
| -3% | -$30.4K | 0.2% | 57 |
|
|
2021
Q2 | $1.11M | Sell |
12,005
-848
| -7% | -$78.4K | 0.24% | 50 |
|
|
2021
Q1 | $1.14M | Sell |
12,853
-777
| -6% | -$68.9K | 0.28% | 47 |
|
|
2020
Q4 | $1.27M | Buy |
13,630
+563
| +4% | +$52.6K | 0.34% | 40 |
|
|
2020
Q3 | $833K | Sell |
13,067
-204
| -2% | -$13K | 0.28% | 48 |
|
|
2020
Q2 | $692K | Buy |
13,271
+4,256
| +47% | +$222K | 0.27% | 48 |
|
|
2020
Q1 | $282K | Buy |
+9,015
| New | +$282K | 0.15% | 74 |
|